Medtronic plc (MDT) (Q1FY24)
Stock Performance – Medtronic’s stock price showed a downward trend in past 3-months. The stock declined by 12.73% during the period. The price declined by 6.97% in past 1-year. The stock has a 52- week high of $92.02 and its 52-week low is $70.95.
In the past 3 years, the stock has declined by 29.9%. MDT has a 50-day moving Avg. and 200-day moving Avg. of $80.26 and $83.23, respectively.
Revenue Performance – MDT revenue was $7.7bn increased 4.5% asreported and 6.0% organic in Q1FY24.
Company Guidance for FY24 – The company increased its FY24 organic revenue growth guidance to 4.5% versus the prior range of 4% to 4.5%. The organic revenue growth guidance excludes the impact of foreign currency and revenue related to certain businesses reported as Other.
The company’s performance has been bolstered by a compelling mix of businesses experiencing steady, long – term growth, further amplified by its strong geographic presence. High single-digit growth was observed in established market leaders such as Cardiac Rhythm Management, Spine, and Surgical sectors.
This report is useful for M&A, business & investment analysis to all students, researchers, investors, private equity houses, broking firms, hedge funds, advisory firms and corporates to decide upon their investment strategies. Do connect with us, if you are looking for equity valuation, recommendation, analysis and market recommendation for any specific company, sector and industry.
– Enterprise Value
– CrispIdea Forecast
– CrispIdea Segment Forecast
– Economic Value Added Analysis
– Discounted Cash Flow Analysis
– P/E Analysis
– Peer Valuation
– CrispIdea Forecast Relative to Consensus
– Consensus History and Surprise
– Consensus Momentum
Actual & Historical Performance
– Income Statement
– Balance Sheet
– Cash Flow
– 10 Year Historical Performance
– Ratio Analysis
– Du Pont Analysis
– ROIC & ROCE Analysis
– Segment Performance
– Price Performance
Stock Price Performance
No of Pages: 36
To download the previous quarter’s equity/report CLICK HERE
To Download other equity/reports CLICK HERE
Follow our LinkedIn page for more updates.